Found 5 matching trials
Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19 PHASE4 Study hypothesis: the viral neutralizing monoclonal antibodies Tiksagevimab...
Show More Location
Moscow City Clinical Hospital 52
Learn More & Join Trial
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB) N/A Absence of anti-SARS-CoV-2 vaccine response or insufficient vaccine respons...
Show More Location
Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospital
Learn More & Join Trial
To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects PHASE1 This is a Phase I study that randomized, double-blind, Placebo-controlled, ...
Show More Location
Chungnam National University Hospital
Learn More & Join Trial
A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection PHASE2 This was a Phase 2/3 study to assess the efficacy about therapeutic effect ...
Show More Location
Chungnam National University Hospital
Learn More & Join Trial
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) PHASE1 This is a Phase I study that randomized, double-blind, Placebo-controlled, ...
Show More Location
Incheon Medical Center
Learn More & Join Trial